8-28天发热新生儿应用Rochester标准联合血清CRP或降钙素原检测的可靠性
该回顾性研究纳入2018年1月至2022年12月就诊于儿科急诊的191例8-28天发热无明确感染源新生儿,仅纳入按Rochester标准完成检查并检测血清生物标志物者,其中54例(28.27%)存在侵袭性细菌感染和/或尿路感染。多因素logistic回归显示较高CRP(p<0.001)和PCT(p=0.013)水平与侵袭性细菌感染和尿路感染相关。Rochester标准联合PCT<0.5 ng/mL(长庚标准)排除侵袭性细菌感染和尿路感染的阴性预测值为100.00%,高于单用Rochester标准的93.06%,阳性预测值相近(分别为40.60%和41.18%)。长庚标准在2023年42例8-28天发热无明确感染源新生儿队列中得到验证。
要点
- 在8-28天发热无明确感染源新生儿中,Rochester标准联合PCT<0.5 ng/mL(长庚标准)排除侵袭性细菌感染和尿路感染的阴性预测值为100.00%,单用Rochester标准为93.06%。
- 长庚标准与单用Rochester标准的阳性预测值相近,分别为40.60%和41.18%。
- 多因素logistic回归显示较高CRP(p<0.001)和PCT(p=0.013)水平与侵袭性细菌感染和尿路感染相关。
- 191例8-28天发热无明确感染源新生儿中54例(28.27%)存在侵袭性细菌感染和/或尿路感染。
- 长庚标准在2023年42例8-28天发热无明确感染源新生儿队列中得到验证。
适用人群与场景
- 8-28天发热无明确感染源新生儿,就诊于儿科急诊。
- 仅纳入按Rochester标准完成检查并检测血清生物标志物者。
诊断标准与关键阈值
- Rochester标准联合PCT<0.5 ng/mL定义为长庚标准,用于排除侵袭性细菌感染和尿路感染。
研究设计与关键结果
- 研究类型为回顾性研究,纳入191例8-28天发热无明确感染源新生儿,其中54例(28.27%)存在侵袭性细菌感染和/或尿路感染。
- 多因素logistic回归显示较高CRP(p<0.001)和PCT(p=0.013)水平与侵袭性细菌感染和尿路感染相关。
- 长庚标准排除侵袭性细菌感染和尿路感染的阴性预测值为100.00%,单用Rochester标准为93.06%。
- 长庚标准与单用Rochester标准的阳性预测值分别为40.60%和41.18%。
- 长庚标准在2023年42例8-28天发热无明确感染源新生儿队列中得到验证。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在8-28天发热无明确感染源新生儿中,使用PCT阈值0.5 ng/mL联合Rochester标准(长庚标准)可为排除侵袭性细菌感染和尿路感染提供更高的阴性预测值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the utility of measuring serum C-reactive protein (CRP) or procalcitonin (PCT) level in conjunction with the Rochester criteria to exclude invasive bacterial infection (IBI) and urinary tract infection (UTI) in neonates aged 8-28 days with fever without an identifiable source of infection (FWSI).
METHODS: The medical records of all neonates aged 8-28 days with FWSI presenting to our pediatric emergency department between January 2018 and December 2022 were analyzed retrospectively. Only those who underwent workup based on the Rochester criteria with the serum biomarkers were included. Our findings were validated in a separate cohort in 2023.
RESULTS: In total, 191 neonates were included in the study, 54 (28.27 %) of whom had IBI and/or UTI. Serum biomarkers were analyzed, and higher CRP (p < 0.001) and PCT (p = 0.013) levels were found to be associated with IBI and UTI on multivariate logistic regression analysis. To exclude IBI and UTI, combining the Rochester criteria with a PCT < 0.5 ng/mL (Chang Gung criteria) had a higher negative predictive value (NPV) of 100.00 % than the Rochester criteria alone (93.06 %) and a similar positive predictive value (40.60 % and 41.18 %, respectively). Chang Gung criteria was validated in a cohort of 42 neonates aged 8-28 days with FWSI in 2023.
CONCLUSION: Using PCT at a threshold of 0.5 ng/mL alongside the Rochester criteria (Chang Gung criteria) provides a higher NPV for excluding IBI and UTI in neonates aged 8-28 days with FWSI.
参考来源
- Lee J, Lee EP, Wu WH, et al. Reliability of measuring serum C-reactive protein or procalcitonin with Rochester criteria in febrile neonates aged 8-28 days. Am J Emerg Med. 2025. PMID: 40250143. doi:10.1016/j.ajem.2025.04.015
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。